Advances in research on vitamin D deficiency and hypertension
Author:
Affiliation:

Cardiovascular Department, The First Hospital of Lanzhou University, Lanzhou, Gansu 730000)

Clc Number:

R5

  • Article
  • | |
  • Metrics
  • |
  • Reference [35]
  • | | | |
  • Comments
    Abstract:

    Vitamin D is a fat-soluble vitamin that has been currently known to play a major role in regulating calcium and bone metabolism. In recent years, although many researchers have found that the incidence of vitamin D deficiency in hypertensive patients is high, vitamin D deficiency may lead to the occurrence and development of hypertension, many results between vitamin D supplementation and hypertension are inconsistent. Here, this article aims to summarize the advance in studies between vitamin D deficiency and hypertension.

    Reference
    [1] Roth GA, Johnson C, Abajobir A, et al.Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015 .J Am Coll Cardiol, 7,0(1):1-25.
    [2] Sarganas G, Schaffrath Rosario A, Niessner C, et al.Tracking of blood pressure in children and adolescents in Germany in the context of risk factors for hypertension .Int J Hypertens, 8,8:8429891.
    [3] NCD Risk Factor Collaboration (NCD-RisC).Worldwide trends in blood pressure from 1975 to 2015:a pooled analysis of 1479 population-based measurement studies with 19.1 million participants .Lancet, 7,9(10064):37-55.
    [4] 胡盛寿, 高润霖, 刘力生, 等.《中国心血管病报告2018》概要.中国循环杂志, 9,4(3):209-220.
    [5] Kearney PM, Whelton M, Reynolds K, et al.Global burden of hypertension:analysis of worldwide data .Lancet, 5,5(9455):217-223.
    [6] Thomopoulos C, Parati G, Zanchetti A.Effects of blood-pressure-lowering treatment on outcome incidence.12.Effects in individuals with high-normal and normal blood pressure:overview and meta-analyses of randomized trials .J Hypertens, 7,5(11):2150-2160.
    [7] Pilz S, Marz W, Cashman KD, et al.Rationale and plan for vitamin D food fortification:a review and guidance paper .Front Endocrinol (Lausanne), 8,9:373.
    [8] Christakos S, Dhawan P, Verstuyf A, et al.Vitamin D:metabolism, molecular mechanism of action, and pleiotropic effects .Physiol Rev, 6,6(1):365-408.
    [9] G R, Gupta A.Vitamin D deficiency in India:prevalence, causalities and interventions .Nutrients, 4,6(2):729-775.
    [10] Spiller HA, Good TF, Spiller NE, et al.Vitamin D exposures reported to US poison centers 2000-2014:Temporal trends and outcomes .Hum Exp Toxicol, 6,5(5):457-461.
    [11] Eriksen EF, Glerup H.Vitamin D deficiency and aging:implications for general health and osteoporosis .Biogerontology, 2,3(1-2):73-77.
    [12] Roth DE, Abrams SA, Aloia J, et al.Global prevalence and disease burden of vitamin D deficiency:a roadmap for action in low-and middle-income countries .Ann N Y Acad Sci, 8,0(1):44-79.
    [13] Scragg R, Sowers M, Bell C.Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey .Am J Hypertens, 7,0(7):713-719.
    [14] Chen CH, Liu LK, Chen MJ, et al.Associations between vitamin D deficiency, musculoskeletal health, and cardiometabolic risk among community-living people in Taiwan:age and sex-specific relationship .Medicine (Baltimore), 8,7(52):e13886.
    [15] Tomaino K, Romero KM, Robinson CL, et al.Association between serum 25-hydroxy vitamin D levels and blood pressure among adolescents in two resource-limited settings in Peru .Am J Hypertens, 5,8(8):1017-1023.
    [16] Moore CE, Liu Y.Elevated systolic blood pressure of children in the United States is associated with low serum 25-hydroxyvitamin D concentrations related to body mass index:National Health and Examination Survey 2007-2010 .Nutr Res, 7,8:64-70.
    [17] Burgess ED, Hawkins RG, Watanabe M.Interaction of 1,5-dihydroxyvitamin D and plasma renin activity in high renin essential hypertension .Am J Hypertens, 0,3(12 Pt 1):903-905.
    [18] Weng S, Sprague JE, Oh J, et al.Vitamin D deficiency induces high blood pressure and accelerates atherosclerosis in mice .PLoS One, 3,8(1):e54625.
    [19] Xiang W, Kong J, Chen S, et al.Cardiac hypertrophy in vitamin D receptor knockout mice:role of the systemic and cardiac renin-angiotensin systems .Am J Physiol Endocrinol Metab, 5,8(1):E125-132.
    [20] Tomaschitz A, Pilz S, Ritz E, et al.Independent association between 1,5-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system:The Ludwigshafen Risk and Cardiovascular Health (LURIC) study .Clin Chim Acta, 0,1(17-18):1354-1360.
    [21] Pilz S, Gaksch M, Kienreich K, et al.Effects of vitamin D on blood pressure and cardiovascular risk factors:a randomized controlled trial .Hypertension, 5,5(6):1195-1201.
    [22] Grübler MR, Gaksch M, Kienreich K, et al.Effects of Vitamin D supplementation on plasma aldosterone and rennin:a randomized placebo-controlled trial .J Clin Hypertens, 6,8(7):608-613.
    [23] Wang F, Han L, Hu D.Fasting insulin, insulin resistance and risk of hypertension in the general population:a meta-analysis .Clin Chim Acta, 7,4:57-63.
    [24] Altieri B, Grant WB, Della Casa S, et al.Vitamin D and pancreas:the role of sunshine vitamin in the pathogenesis of diabetes mellitus and pancreatic cancer .Crit Rev Food Sci Nutr, 7,7(16):3472-3488.
    [25] Garbossa SG, Folli F.Vitamin D, sub-inflammation and insulin resistance.A window on a potential role for the interaction between bone and glucose metabolism .Rev Endocr Metab Disord, 7,8(2):243-258.
    [26] Szymczak-Pajor I, Sliwinska A.Analysis of association between vitamin D deficiency and insulin resistance .Nutrients, 9,1(4):E794.
    [27] Fujii H.Association between parathyroid hormone and cardiovascular disease .Ther Apher Dial, 8,2(3):236-241.
    [28] Lotito A, Teramoto M, Cheung M, et al.Serum parathyroid hormone responses to vitamin D supplementation in overweight/obese adults:a systematic review and meta-analysis of randomized clinical trials .Nutrients, 7,9(3):E241.
    [29] Vimaleswaran KS, Cavadino A, Berry DJ, et al.Association of vitamin D status with arterial blood pressure and hypertension risk:a mendelian randomisation study .Lancet Diabetes Endocrinol, 4,2(9):719-729.
    [30] Ni W, Watts SW, Ng M, et al.Elimination of vitamin D receptor in vascular endothelial cells alters vascular function .Hypertension, 4,4(6):1290-1298.
    [31] Talmor Y, Golan E, Benchetrit S, et al.Calcitriol blunts the deleterious impact of advanced glycation end products on endothelial cells .Am J Physiol Renal Physiol, 8,4(5):F1059-1064.
    [32] Forman JP, Scott JB, Ng K, et al.Effect of vitamin d supplementation on blood pressure in blacks .Hypertension, 3,1(4):779-785.
    [33] Mozaffari-Khosravi H, Loloei S, Mirjalili MR, et al.The effect of vitamin D supplementation on blood pressure in patients with elevated blood pressure and vitamin D deficiency:a randomized, double-blind, placebo-controlled trial .Blood Press Monit, 5,0(2):83-91.
    [34] Qi D, Nie X, Cai J.The effect of vitamin D supplementation on hypertension in non-CKD populations:a systemic review and meta-analysis .Int J Cardiol, 7,7:177-186.
    [35] Mirhosseini N, Rainsbury J, Kimball SM.Vitamin D supplementation, serum 25(OH)D concentrations and cardiovascular disease risk factors:a systematic review and meta-analysis .Front Cardiovasc Med, 8,5:87.
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

SHI Lingxia, ZHANG Jin. Advances in research on vitamin D deficiency and hypertension[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2020,28(2):181-184.

Copy
Share
Article Metrics
  • Abstract:829
  • PDF: 822
  • HTML: 0
  • Cited by: 0
History
  • Received:May 27,2019
  • Revised:June 23,2019
  • Online: January 20,2020
Article QR Code